|Publication number||US5839429 A|
|Application number||US 08/915,121|
|Publication date||Nov 24, 1998|
|Filing date||Aug 20, 1997|
|Priority date||Mar 25, 1994|
|Publication number||08915121, 915121, US 5839429 A, US 5839429A, US-A-5839429, US5839429 A, US5839429A|
|Inventors||Nils Goran Marnfeldt, Johan Mats Bertil Waldeck|
|Original Assignee||Astra Aktiebolag|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (13), Referenced by (49), Classifications (11), Legal Events (5)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation of application Ser. No. 08/436,434, filed as PCT/SE95/00315 Mar. 24, 1995 published as WO95/26212 Oct. 5, 1995, now abandoned.
The present invention relates to a method and an apparatus for training a patient to use an inhaler.
In order that a breath-activated dry powder inhaler should release a dose of a drug contained therein and the dose should reach far enough into the lungs of the patient inhaling through the inhaler, the inhalation flow must reach a certain critical limit. Since the patient cannot tell the difference between an inhalation containing a dose of a drug and an inhalation not containing any dose of the drug, it is difficult for him to know whether he has actually received his dose or not. Therefore, it is important that the patient learns how to use the inhaler correctly right from the beginning and also that he and his doctor can check his use of the inhaler occasionally.
Today, there does not exist any suitable apparatus for training and checking the use of a breath-activated dry powder inhaler. Sometimes, an inhaler is connected to equipment for performing pulmonary function tests (PFT). The inhalation flow is displayed as a function of time on a screen, and a doctor assesses whether the inhalation is correctly performed. However, the PFT equipment is very expensive and may thus be used only at hospitals and the like. Furthermore, a person must be present to instruct the patient, operate the equipment and assess the result.
Accordingly, a first object of the present invention is to provide an apparatus for training a patient to use an inhaler correctly, this apparatus being inexpensive and easy to use and dispensing with the need of any assistance from trained personnel.
A second object of the present invention is to provide a method for training a patient to use an inhaler correctly.
These objects are achieved by an apparatus and a method having the features recited in the appended claims.
The apparatus according to the invention provides interactive directions for the correct use of an inhaler. The apparatus can be used by everyone without any assistance, since the use of it is self-explanatory. Each step to be performed is indicated to the patient in turn, and the inhalation flow is not measured until a correct activation of the inhaler for making a dose available has been detected. The apparatus comprises an inhaler which is similar to the one the patient normally uses or will use so that the training is realistically performed.
One embodiment of the apparatus and the method according to the present invention will now be described in more detail with reference to the accompanying drawings, in which
FIG. 1 is a schematic view showing an embodiment of an apparatus according to the present invention;
FIG. 2 is a block diagram, showing electronical components of the apparatus in FIG. 1; and
FIG. 3 is a flow diagram, showing the operation of the apparatus in FIG. 1.
As appears from FIG. 1, a training apparatus according to the present invention substantially consists of an inhaler 1 and a box-shaped portable processing device 2, to which the inhaler is connected by a cable 3.
The inhaler 1 is a TURBUHALERŽ inhaler, the substance container of which is empty or holds an ineffective substance in the form of a dry powder. It has a replaceable mouthpiece 4 made of e.g. plastics, and a gripping ring 5, which is to be turned in order to make a dose available for inhalation.
On its upper side, the processing device 2 is provided with a switch 6 for turning on the apparatus, and a plurality of light-emitting diodes 7-11 for indicating the different steps to be taken as well as the inhalation flow. Furthermore, there is a picture 12 of a TURBUHALERŽinhaler with two arrows indicating how the inhaler is to be operated in order to make a dose available, and a picture 13 indicating inhalation through the inhaler.
Furthermore, the training apparatus comprises means for detecting the activation of the inhaler in order to make a dose available for inhalation and for detecting the inhalation flow. Such means may be of the kind disclosed in EP 387 222 and will be briefly described in the following with reference to FIG. 2.
A microphone 16 is arranged in the inhaler 1 close to an inhalation channel (not shown) therein. The microphone 16 is connected to processing means in the processing device 2 by the cable 3.
The microphone 16 detects the characteristic click sound created when the gripping ring 5 is turned, as well as the sound of the airflow at an inhalation. These signals are transferred to the processing device 2 via the cable 3.
A first branch 14 of the processing device, which is adapted to process the click sound, comprises a rectifier 24 which rectifies the click sound signal. The rectifier 24 is connected to an amplifier 25, which amplifies the rectified signal to about 1 V. The amplified signal is input into a puls stretcher 26, which stretches the amplified signal to a signal which can be recorded as a valid activation of the inhaler in a processor 27.
A second branch 15 of the processing device, which is adapted to process the inhalation flow signal, comprises a band pass filter 18, which passes a signal within a limited frequency range. The filtered signal is input into an amplifier 19, which amplifies the signal to about 1 V. The amplified signal is rectified and low-pass filtered in a detector 20 so that the envelope of the signal is obtained. Then, the envelope signal, which represents the momentary inhalation flow, is A/D-converted in a A/D-converter 22 before being input into the processor 27. In addition to the inputs from the first and second branches 14, 15, the processor 27 have outputs to the LED's 7-11 on the upper side.
The operation of the apparatus shown in FIGS. 1 and 2 will now be described with reference to the flow diagram in FIG. 3.
When the processor 27 detects (step 30) that the training apparatus has been turned on by the pressing of the switch 6, it turns on all the LED's 7-11 for a short while and measures the battery voltage to check whether it is sufficient for performing one or more training cycles (step 31). If the battery is discharged, the processor 27 turns off the apparatus (step 32), whereas if the battery is sufficiently charged, the processor 27 turns on the LED 7 to indicate that the gripping ring 5 is to be turned in order to make a dose available (step 33). When the processor receives a signal which represents a proper turning of the gripping ring 5 as detected by the microphone 16 (step 34), it turns off the LED 7 and turns on the LED 8 to urge the patient to inhale through the inhaler (step 35). When the patient inhales through the inhaler, the sound of the inhalation flow is detected by the microphone (step 36). The signal from the microphone 16 is processed in the second branch 15 and input into the processor 27, which determines the size of the inhalation flow (step 37) and turns on one or more of the LEDs 9-11, each LED corresponding to a different inhalation flow achieved. As an example, the first LED 9 may be turned on at an inhalation flow of 30 l/min, the second LED 10 at 40 l/min and the third LED 11 at 60 l/min.
The levels at which the different LEDs are turned on may be changed without opening the processing device 2. To this end, the processing device comprises a calibration switch arranged inside its cover. The calibration switch is operable from the outside of the cover by means of a magnetic element. To transfer the apparatus to a calibration mode both the calibration switch and the switch 6 must be activated at the same time. When the calibration mode is entered, the processor 27 turns on the first LED 9. Then, the turning-on level of the first LED 9 can be set by feeding a flow corresponding to the desired turning-on level through the inhaler and, at the same time, pressing the switch 6. When the level of the first LED 9 has been set, the processor turns off the first LED 9 and turns on the second LED 10, the level of which may now be set. Finally, the level of the third LED 11 may be set in the same way.
The calibrated turning-on levels of the LEDs are stored in a non-volatile memory 28, from which they are fetched when the processor 27 determines which LED(s) to turn on for indicating the inhalation flow.
Since it is important that the inhaler is held in a substantially vertical position, at least not deviating more than 45 degrees from the vertical, when the inhaler is activated for making a dose available, the inhaler may, as a further feature, be provided with a position transducer. The position transducer may be connected to the processing device 2 via the cable 3. In this case, the processing device 2 need to detect both the click sound created when the inhaler is activated for making a dose available and a correct position of the inhaler during the activation, in order that it shall turn on the LED 8 for urging the patient to inhale through the inhaler.
In the embodiment described above a microphone is used for the detection of the activation of the inhaler and for the detection of the inhalation flow. Alternatively, other means, such as a pressure transducer, can be used.
The method and the apparatus according to the present invention can be used to train a person to use any kind of inhaler, where first the dose is made available for inhalation and then the inhalation is performed. For instance, the inhaler may be a breath-activated dry powder inhaler, in particular a TURBUHALERŽ inhaler.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3809294 *||Jun 27, 1973||May 7, 1974||American Cyanamid Co||Dispensing lung contacting powdered medicaments|
|US3897779 *||Jun 27, 1973||Aug 5, 1975||American Cyanamid Co||Triamcinolone acetonide inhalation therapy|
|US4495944 *||Feb 7, 1983||Jan 29, 1985||Trutek Research, Inc.||Inhalation therapy apparatus|
|US4984158 *||Oct 14, 1988||Jan 8, 1991||Hillsman Dean||Metered dose inhaler biofeedback training and evaluation system|
|US5019974 *||Feb 22, 1990||May 28, 1991||Diva Medical Systems Bv||Diabetes management system and apparatus|
|US5152456 *||Dec 3, 1990||Oct 6, 1992||Bespak, Plc||Dispensing apparatus having a perforate outlet member and a vibrating device|
|US5167506 *||Oct 24, 1991||Dec 1, 1992||Minnesota Mining And Manufacturing Company||Inhalation device training system|
|US5284133 *||Jul 23, 1992||Feb 8, 1994||Armstrong Pharmaceuticals, Inc.||Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means|
|US5331953 *||Mar 2, 1990||Jul 26, 1994||Aktiebolaget Draco||Device in connection with an inhaler|
|EP0387222A1 *||Mar 2, 1990||Sep 12, 1990||Aktiebolaget Draco||Device in connection with an inhaler|
|GB2164569A *||Title not available|
|WO1992015353A2 *||Mar 3, 1992||Sep 17, 1992||Miris Medical Corporation||Delivery of aerosol medications for inspiration|
|WO1993012823A2 *||Dec 18, 1992||Jul 8, 1993||Circadian, Inc.||Intelligent inhaler providing feedback to both patient|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US6142146 *||Jun 12, 1998||Nov 7, 2000||Microdose Technologies, Inc.||Inhalation device|
|US6305371 *||May 8, 1998||Oct 23, 2001||Astrazeneca Ab||Inhalation for administering medicament by inhalation|
|US6484717 *||May 8, 1998||Nov 26, 2002||Astra Aktiebolag||Inhalation device|
|US7047964||Jan 24, 2002||May 23, 2006||Clinical Designs Ltd.||Dispenser for medicament|
|US7814900||Mar 17, 2003||Oct 19, 2010||Clinical Designs Limited||Can fixture|
|US7896002 *||Jul 12, 2007||Mar 1, 2011||Canon Kabushiki Kaisha||Medicine discharge device and cartridge mountable thereto|
|US8329271||Dec 14, 2005||Dec 11, 2012||Clinical Designs Limited||Medicament container|
|US8408208||Dec 10, 2004||Apr 2, 2013||Clinical Designs Limited||Dispenser and counter|
|US8424518||Jun 12, 2009||Apr 23, 2013||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US8485180||Mar 4, 2010||Jul 16, 2013||Mannkind Corporation||Dry powder drug delivery system|
|US8499757||Jun 12, 2009||Aug 6, 2013||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US8636001||Jun 12, 2009||Jan 28, 2014||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US8912193||Jun 18, 2013||Dec 16, 2014||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9035765||Aug 27, 2014||May 19, 2015||Gecko Health Innovations, Inc.||Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers|
|US9114221||Mar 10, 2010||Aug 25, 2015||Euro-Celtique S.A.||Counter|
|US9192675||Jul 30, 2013||Nov 24, 2015||Mankind Corporation||Dry powder inhaler and system for drug delivery|
|US9220687||Nov 7, 2014||Dec 29, 2015||Mannkind Corporation||Substituted diketopiperazine analogs for use as drug delivery agents|
|US9233159||Oct 24, 2012||Jan 12, 2016||Mannkind Corporation||Methods and compositions for treating pain|
|US9241903||Jul 15, 2013||Jan 26, 2016||Mannkind Corporation||Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent|
|US9283193||Apr 10, 2014||Mar 15, 2016||Mannkind Corporation||Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents|
|US9339615||Mar 14, 2013||May 17, 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9346766||Apr 30, 2014||May 24, 2016||Mannkind Corporation||Catalysis of diketopiperazine synthesis|
|US9358352||Jun 21, 2011||Jun 7, 2016||Mannkind Corporation||Dry powder drug delivery system and methods|
|US9364436||Jun 18, 2012||Jun 14, 2016||Mannkind Corporation||High capacity diketopiperazine microparticles and methods|
|US9364619||Jun 19, 2009||Jun 14, 2016||Mannkind Corporation||Interactive apparatus and method for real-time profiling of inhalation efforts|
|US9393372||Jul 2, 2013||Jul 19, 2016||Mannkind Corporation||Dry powder drug delivery system|
|US9415178||Mar 10, 2010||Aug 16, 2016||Euro-Celtique S.A.||Counter|
|US9446001||Jun 22, 2015||Sep 20, 2016||Mannkind Corporation||Increasing drug affinity for crystalline microparticle surfaces|
|US9446133||Oct 21, 2014||Sep 20, 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9511198||Nov 27, 2013||Dec 6, 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9610351||Feb 13, 2015||Apr 4, 2017||Mannkind Corporation||Methods and compositions for treating pain|
|US9630930||Apr 11, 2014||Apr 25, 2017||Mannkind Corporation||Diketopiperazine microparticles with defined specific surface areas|
|US9655850||Nov 18, 2015||May 23, 2017||Mannkind Corporation||Substituted diketopiperazine analogs for use as drug delivery agents|
|US9662461||May 2, 2016||May 30, 2017||Mannkind Corporation||Dry powder drug delivery system and methods|
|US9675674||Jan 8, 2016||Jun 13, 2017||Mannkind Corporation||Diketopiperazine salts for drug delivery and related methods|
|US9700690||Jun 12, 2014||Jul 11, 2017||Mannkind Corporation||Inhalation apparatus|
|US9706944||Mar 24, 2015||Jul 18, 2017||Mannkind Corporation||Apparatus and method for simulating inhalation efforts|
|US9707360||Feb 18, 2015||Jul 18, 2017||Clinical Designs Limited||Substance source|
|US9717689||Feb 5, 2016||Aug 1, 2017||Mannkind Corporation||Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents|
|US9728068||May 1, 2015||Aug 8, 2017||Gecko Health Innovations, Inc.||Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers|
|US20040069301 *||Jan 24, 2002||Apr 15, 2004||Bacon Raymond John||Dispenser for medicament|
|US20040187869 *||Jan 16, 2004||Sep 30, 2004||Schering Corporation||Training device for medicament inhalers|
|US20070017506 *||Jun 4, 2004||Jan 25, 2007||Phillip Bell||Dispensing apparatus|
|US20080023001 *||Jul 12, 2007||Jan 31, 2008||Canon Kabushiki Kaisha||Medicine discharge device and cartridge mountable thereto|
|US20100089394 *||May 30, 2008||Apr 15, 2010||Canon Kabushiki Kaisha||Inhaler and driving method for same|
|US20160144142 *||Nov 24, 2014||May 26, 2016||Jeff Baker||Metered dose respiratory training device and system|
|WO2002058771A1||Jan 24, 2002||Aug 1, 2002||Clinical Designs Limited||Dispenser for medicament|
|WO2004064705A3 *||Jan 16, 2004||Dec 23, 2004||Paul M Bjorndal||Training device for medicament inhalers|
|WO2016085988A3 *||Nov 24, 2015||Aug 11, 2016||DESANTO, Kristin||Metered dose respiratory training device and system|
|U.S. Classification||128/200.14, 128/203.15, 128/204.23, 128/205.23|
|International Classification||A61M15/00, A61M16/00|
|Cooperative Classification||A61M2205/215, A61M2016/0021, A61M15/00, A61M2205/8206|
|Apr 29, 2002||FPAY||Fee payment|
Year of fee payment: 4
|Apr 26, 2006||FPAY||Fee payment|
Year of fee payment: 8
|Jun 28, 2010||REMI||Maintenance fee reminder mailed|
|Nov 24, 2010||LAPS||Lapse for failure to pay maintenance fees|
|Jan 11, 2011||FP||Expired due to failure to pay maintenance fee|
Effective date: 20101124